Last 12 months
Inside the activity.
1 purchase rows · 24 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 2 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 7 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 02, 2023 Filed Feb 6, 2023 22:10 UTC |
Anevski PeterDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 32,000 | $3.95 | $126,400.00 |
DisclosureSEC source: 0001628280-23-002438 · wf-form4_167572142317038.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 807 common shares acquired under the Issuer's employee stock purchase plan. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 21:22 UTC |
Schlanger David JDirector · Executive Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-23-002053 · wf-form4_167537292875614.xml · derivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,132,395 Underlying: Common Stock · 100,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 21:22 UTC |
Schlanger David JDirector · Executive Chairman
|
SaleCommon Stock | 100,000 | $35.18 | $3,518,000.00 |
DisclosureSEC source: 0001628280-23-002053 · wf-form4_167537292875614.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,716 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 21:22 UTC |
Schlanger David JDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 100,000 | $0.91 | $91,000.00 |
DisclosureSEC source: 0001628280-23-002053 · wf-form4_167537292875614.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 21:26 UTC |
Anevski PeterDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-002056 · wf-form4_167537315039439.xml · derivative · entry 8 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,322,820 Underlying: Common Stock · 32,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 21:26 UTC |
Anevski PeterDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 8,000 | $35.14 | $281,120.00 |
DisclosureSEC source: 0001628280-23-002056 · wf-form4_167537315039439.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 148,414 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 21:26 UTC |
Anevski PeterDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 32,000 | $35.14 | $1,124,480.00 |
DisclosureSEC source: 0001628280-23-002056 · wf-form4_167537315039439.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,093 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 21:26 UTC |
Anevski PeterDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 32,000 | $3.95 | $126,400.00 |
DisclosureSEC source: 0001628280-23-002056 · wf-form4_167537315039439.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,093 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:22 UTC |
Schlanger David JDirector · Executive Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,285 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-23-002053 · wf-form4_167537292875614.xml · derivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,232,395 Underlying: Common Stock · 1,285 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:22 UTC |
Schlanger David JDirector · Executive Chairman
|
SaleCommon Stock | 1,285 | $35.00 | $44,975.00 |
DisclosureSEC source: 0001628280-23-002053 · wf-form4_167537292875614.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,716 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:22 UTC |
Schlanger David JDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 1,285 | $0.91 | $1,169.35 |
DisclosureSEC source: 0001628280-23-002053 · wf-form4_167537292875614.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:26 UTC |
Anevski PeterDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 735 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-002056 · wf-form4_167537315039439.xml · derivative · entry 7 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,354,820 Underlying: Common Stock · 735 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:26 UTC |
Anevski PeterDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 184 | $35.00 | $6,440.00 |
DisclosureSEC source: 0001628280-23-002056 · wf-form4_167537315039439.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 156,414 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:26 UTC |
Anevski PeterDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 735 | $35.00 | $25,725.00 |
DisclosureSEC source: 0001628280-23-002056 · wf-form4_167537315039439.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,093 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:26 UTC |
Anevski PeterDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 735 | $3.95 | $2,903.25 |
DisclosureSEC source: 0001628280-23-002056 · wf-form4_167537315039439.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,828 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2023 Filed Jan 27, 2023 21:49 UTC |
Livingston Mark S.CHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 259 | $32.78 | $8,490.02 |
DisclosureSEC source: 0001628280-23-001673 · wf-form4_167485611861795.xml · nonDerivative · entry 1 Livingston Mark S. · CIK 0001824161 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,968 F1 · shares: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:19 UTC |
Anevski PeterDirector · CHIEF EXECUTIVE OFFICER
|
Tax withholdingCommon Stock | 27,352 | $31.15 | $852,014.80 |
DisclosureSEC source: 0001628280-23-000458 · wf-form4_167295352782882.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,093 F1 · shares: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:17 UTC |
Schlanger David JDirector · Executive Chairman
|
Tax withholdingCommon Stock | 7,832 | $31.15 | $243,966.80 |
DisclosureSEC source: 0001628280-23-000456 · wf-form4_167295343834763.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,716 F1 · kind: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| December 22, 2022 Filed Dec 27, 2022 21:22 UTC |
Payson NormanDirector
|
SaleCommon Stock | 6,617 | $30.89 | $204,399.13 |
DisclosureSEC source: 0001628280-22-032590 · wf-form4_167217616376591.xml · nonDerivative · entry 1 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 272,446 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 9, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.35 to $31.295, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| December 21, 2022 Filed Dec 22, 2022 21:59 UTC |
Payson NormanDirector
|
SaleCommon Stock | 6,617 | $31.65 | $209,428.05 |
DisclosureSEC source: 0001628280-22-032493 · wf-form4_167174632359756.xml · nonDerivative · entry 1 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 279,063 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 9, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.34 to $32.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 21:02 UTC |
Livingston Mark S.CHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 79 | $32.58 | $2,573.82 |
DisclosureSEC source: 0001628280-22-031798 · wf-form4_167096531405577.xml · nonDerivative · entry 1 Livingston Mark S. · CIK 0001824161 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,227 F1 · shares: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| December 08, 2022 Filed Dec 9, 2022 21:07 UTC |
Payson NormanDirector
|
SaleCommon Stock | 6,017 | $32.70 | $196,755.90 |
DisclosureSEC source: 0001628280-22-031664 · wf-form4_167062002174536.xml · nonDerivative · entry 5 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 285,680 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 9, 2022. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.38 to $33.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| December 08, 2022 Filed Dec 9, 2022 21:07 UTC |
Payson NormanDirector
|
SaleCommon Stock | 600 | $31.86 | $19,116.00 |
DisclosureSEC source: 0001628280-22-031664 · wf-form4_167062002174536.xml · nonDerivative · entry 4 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 291,697 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 9, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.35 to $32.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 21:07 UTC |
Payson NormanDirector
|
SaleCommon Stock | 2,022 | $32.10 | $64,906.20 |
DisclosureSEC source: 0001628280-22-031664 · wf-form4_167062002174536.xml · nonDerivative · entry 3 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 292,297 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 9, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.66 to $32.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 21:07 UTC |
Payson NormanDirector
|
SaleCommon Stock | 2,295 | $31.23 | $71,672.85 |
DisclosureSEC source: 0001628280-22-031664 · wf-form4_167062002174536.xml · nonDerivative · entry 2 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 294,319 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 9, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.65 to $31.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 21:07 UTC |
Payson NormanDirector
|
SaleCommon Stock | 2,300 | $30.08 | $69,184.00 |
DisclosureSEC source: 0001628280-22-031664 · wf-form4_167062002174536.xml · nonDerivative · entry 1 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 296,614 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 9, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.65 to $30.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:00 UTC |
Livingston Mark S.CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 2,997 | $36.46 | $109,270.62 |
DisclosureSEC source: 0001628280-22-031341 · wf-form4_167027401489272.xml · nonDerivative · entry 2 Livingston Mark S. · CIK 0001824161 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,306 Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:00 UTC |
Livingston Mark S.CHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 1,691 | $36.63 | $61,941.33 |
DisclosureSEC source: 0001628280-22-031341 · wf-form4_167027401489272.xml · nonDerivative · entry 1 Livingston Mark S. · CIK 0001824161 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,303 F1 · shares: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| November 29, 2022 Filed Dec 1, 2022 21:14 UTC |
Livingston Mark S.CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 14,801 | $36.70 | $543,196.70 |
DisclosureSEC source: 0001628280-22-031242 · wf-form4_166992925470094.xml · nonDerivative · entry 1 Livingston Mark S. · CIK 0001824161 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,994 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.57 to $36.805, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 28, 2022 Filed Nov 30, 2022 23:19 UTC |
Swartz AllisonEVP, GC
|
GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $36.92 | $0.00 |
DisclosureSEC source: 0001628280-22-031117 · wf-form4_166985036032076.xml · derivative · entry 2 Swartz Allison · CIK 0001956339 · EVP, GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2032-11-27 F2 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vest on November 28, 2023, and the remaining shares subject to the Option vest in equal quarterly installments thereafter through November 28, 2026, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| November 28, 2022 Filed Nov 30, 2022 23:19 UTC |
Swartz AllisonEVP, GC
|
GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-031117 · wf-form4_166985036032076.xml · nonDerivative · entry 1 Swartz Allison · CIK 0001956339 · EVP, GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 F1 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. One-fourth (1/4th) of the common stock underlying the RSU shall vest on November 28, 2023, and the remaining RSUs shall vest in equal quarterly installments thereafter through November 28, 2026, subject to the Reporting Persons continuing to provide service through each such date. Read SEC document |
| November 25, 2022 Filed Nov 29, 2022 21:09 UTC |
Sturmer Michael EPRESIDENT
|
Tax withholdingCommon Stock | 6,437 | $34.32 | $220,917.84 |
DisclosureSEC source: 0001628280-22-030944 · wf-form4_166975616694240.xml · nonDerivative · entry 1 Sturmer Michael E · CIK 0001837043 · PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,320 F1 · shares: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the reporting person. Read SEC document |
| November 25, 2022 Filed Nov 29, 2022 21:11 UTC |
Livingston Mark S.CHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 158 | $34.32 | $5,422.56 |
DisclosureSEC source: 0001628280-22-030947 · wf-form4_166975626283574.xml · nonDerivative · entry 1 Livingston Mark S. · CIK 0001824161 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,795 F1 · shares: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| November 23, 2022 Filed Nov 28, 2022 21:20 UTC |
Payson NormanDirector
|
SaleCommon Stock | 6,617 | $34.25 | $226,632.25 |
DisclosureSEC source: 0001628280-22-030871 · wf-form4_166967032380637.xml · nonDerivative · entry 1 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 298,914 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 9, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.90 to $34.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:10 UTC |
Payson NormanDirector
|
SaleCommon Stock | 6,617 | $33.80 | $223,654.60 |
DisclosureSEC source: 0001628280-22-030749 · wf-form4_166923780313579.xml · nonDerivative · entry 1 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 305,531 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 9, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.40 to $34.235, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 21:03 UTC |
Payson NormanDirector
|
SaleCommon Stock | 100 | $39.84 | $3,984.00 |
DisclosureSEC source: 0001628280-22-029821 · wf-form4_166845969268321.xml · nonDerivative · entry 6 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 312,148 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 9, 2022. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 21:03 UTC |
Payson NormanDirector
|
SaleCommon Stock | 1,900 | $38.96 | $74,024.00 |
DisclosureSEC source: 0001628280-22-029821 · wf-form4_166845969268321.xml · nonDerivative · entry 5 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 312,248 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 9, 2022. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.60 to $39.445, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 21:03 UTC |
Payson NormanDirector
|
SaleCommon Stock | 4,617 | $37.79 | $174,476.43 |
DisclosureSEC source: 0001628280-22-029821 · wf-form4_166845969268321.xml · nonDerivative · entry 4 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 314,148 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 9, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.525 to $38.46 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 21:03 UTC |
Payson NormanDirector
|
SaleCommon Stock | 900 | $39.55 | $35,595.00 |
DisclosureSEC source: 0001628280-22-029821 · wf-form4_166845969268321.xml · nonDerivative · entry 3 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 318,765 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 9, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.13 to $39.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 21:03 UTC |
Payson NormanDirector
|
SaleCommon Stock | 1,300 | $38.58 | $50,154.00 |
DisclosureSEC source: 0001628280-22-029821 · wf-form4_166845969268321.xml · nonDerivative · entry 2 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 319,665 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 9, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.05 to $39.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 21:03 UTC |
Payson NormanDirector
|
SaleCommon Stock | 4,417 | $37.54 | $165,814.18 |
DisclosureSEC source: 0001628280-22-029821 · wf-form4_166845969268321.xml · nonDerivative · entry 1 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 320,965 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 9, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.03 to $37.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 16:16 UTC |
TPG GP A, LLC10% owner
BONDERMAN DAVID10% owner
COULTER JAMES G10% owner
WINKELRIED JON10% owner
|
SaleCommon Stock | 750,000 | $38.75 | $29,062,500.00 |
DisclosureSEC source: 0001387131-22-011237 · pgny-form4_110922.xml · nonDerivative · entry 1 TPG GP A, LLC · CIK 0001903793 · 10% owner BONDERMAN DAVID · CIK 0000860866 · 10% owner COULTER JAMES G · CIK 0001099776 · 10% owner WINKELRIED JON · CIK 0001366946 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Explanation of Responses Disclosed balance after: 9,250,000 F1 · ownership.nature: Each of David Bonderman, James G. Coulter and Jon Winkelried own entities that own TPG GP A, LLC (together with Messrs. Bonderman, Coulter and Winkelried, the "Reporting Persons"), which is the managing member of TPG Group Holdings (SBS) Advisors, LLC, which is the general partner of TPG Group Holdings (SBS), L.P., which holds 100% of the shares of Class B common stock (which represents a majority of the combined voting power of the common stock) of TPG Inc., which is the managing member of TPG GPCo, LLC, which is the sole member of TPG Holdings I-A, LLC, which is the general partner of TPG Operating Group I, L.P., which is the sole member of TPG Biotechnologies GenPar III Advisors, LLC, which is the general partner of TPG Biotechnology GenPar III, L.P., which is the general partner of TPG Biotechnology Partners III, L.P. ("TPG Biotech III"), which directly holds 9,250,000 shares of Common Stock, $0.0001 par value per share, of Progyny, Inc. F2 · ownership.nature: Because of the relationship between the Reporting Persons and TPG Biotech III, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of TPG Biotech III. Each of TPG Biotech III and each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of TPG Biotech III's or such Reporting Person's pecuniary interest therein, if any. F3 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:03 UTC |
Anevski PeterDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,905 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-22-029212 · wf-form4_166802777819430.xml · derivative · entry 8 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,355,555 Underlying: Common Stock · 25,905 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:03 UTC |
Anevski PeterDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 40 | $41.41 | $1,656.40 |
DisclosureSEC source: 0001628280-22-029212 · wf-form4_166802777819430.xml · nonDerivative · entry 7 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 156,598 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.37 to $41.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:03 UTC |
Anevski PeterDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 4,077 | $40.58 | $165,444.66 |
DisclosureSEC source: 0001628280-22-029212 · wf-form4_166802777819430.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 156,638 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.32 to $41.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:03 UTC |
Anevski PeterDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 2,359 | $39.95 | $94,242.05 |
DisclosureSEC source: 0001628280-22-029212 · wf-form4_166802777819430.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 160,715 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.305 to $40.305, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:03 UTC |
Anevski PeterDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 160 | $41.41 | $6,625.60 |
DisclosureSEC source: 0001628280-22-029212 · wf-form4_166802777819430.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,445 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.37 to $41.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:03 UTC |
Anevski PeterDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 16,307 | $40.58 | $661,738.06 |
DisclosureSEC source: 0001628280-22-029212 · wf-form4_166802777819430.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,605 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.32 to $41.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:03 UTC |
Anevski PeterDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 9,438 | $39.95 | $377,048.10 |
DisclosureSEC source: 0001628280-22-029212 · wf-form4_166802777819430.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,912 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.305 to $40.305, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:03 UTC |
Anevski PeterDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 25,905 | $3.95 | $102,324.75 |
DisclosureSEC source: 0001628280-22-029212 · wf-form4_166802777819430.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.